← Back
Data updated: Mar 10, 2026
KANCHAN HLTHCARE
RespiratoryDermatology
KANCHAN HLTHCARE is a specialty pharmaceutical company focused on Respiratory, Dermatology.
1967
Since
5
Drugs
-
Trials
115
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LACOSAMIDE 2026-01-29
LACOSAMIDE 2026-01-21
VARENICLINE TARTRATE 2026-01-09
VARENICLINE TARTRATE 2025-12-18
Labeling
VARENICLINE TARTRATE 2025-10-29
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Respiratory 50%
1 drugs
Dermatology 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (2)
Company Info
- First Approval
- 1967-11-06
- Latest
- 2024-06-05
- Applications
- 6